SKN | Holtec Nuclear Withdraws $825 Million IPO After Postponement
Key Points:
Holtec Nuclear has withdrawn its planned $825 million IPO after postponing the offering, ending its attempt to raise capital through a Nasdaq...
SKN | Bluerock Acquisition Corp. II Launches $100 Million SPAC IPO on Nasdaq
Bluerock Acquisition Corp. II has launched its initial public offering as a blank-check company, raising $100 million through the sale of 10 million units...
SKN | Pinnacle Acquisition Corporation Raises $200 Million in NYSE SPAC IPO
Pinnacle Acquisition Corporation completed its initial public offering in August 2026, raising $200 million through the sale of 20 million units at $10 each....
SKN | siRNA Biotech ADARx Pharmaceuticals Prices Upsized IPO at $17, High End of Range
ADARx Pharmaceuticals raised $446 million in its initial public offering after pricing an upsized deal at $17 per share, the high end of its...
SKN | RNA Interference Biotech City Therapeutics Files for $100 Million IPO
City Therapeutics, a clinical-stage biotechnology company developing RNA interference therapies, has filed with the SEC to raise up to $100 million in an initial...